Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Jain, K. K. Sharma, P. Gupta, N. Joshi (Jaipur, India). Treatment outcome and one year follow-up status of patients treated under DOTS category II. Eur Respir J 2008; 32: Suppl. 52, 3045

Member's Comments

No comment yet.

Related content which might interest you: To study outcome of directly observered treatment shortcourse (DOTS) category I and category II relapses when put on re-treatment regimen (Cat-II DOTS) Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011 Ambrisentan therapy for PAH patients with WHO class II symptoms: one year follow-up. Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension Year: 2008 Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004 Outcome in DOTS category II patients by strengthening the regimen with daily levofloxacin Source: Annual Congress 2009 - Tuberculosis control Year: 2009 Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases Year: 2017 Outcome of patients discharged from rapid access lung clinic (RALC) with non cancer diagnosis: Five year follow up Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 Treatment outcome and follow-up of new tuberculosis cases discharged from the hospital in 2001 Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005 Clinical outcome of adult onset asthma in a 15 year follow-up Source: Virtual Congress 2020 – Risk factors for chronic lung diseases Year: 2020 TB status in a dynamic cohort of patients with Inflammatory Bowel Disease receiving immunosuppression treatment, with up to 8 years of follow-up. Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I Year: 2019 Demographics, clinical course and outcome of children with status asthmaticus treated in a pediatric critical care unit: 8 year review Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma Year: 2011 Clinical management improves the treatment outcome of MDR-TB patients Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017 Characteristics of lethal outcomes during the first year of observation in patients with tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 424s Year: 2005 Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Treatment strategies for patients with complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Asthma control and quality of life in asthmatic patients treated for 6 months with FDC Budesonide/Formoterol - BOREAS study: a subgroup analysis in patients with comorbidities Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Participation in scheduled asthma follow-up contacts and adherence to treatment during 12-year follow-up Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021 Nutrition status and mortality rate during 5-years follow-up in patients with COPD. Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019 Clinical outcome in patients treated with omalizumab during pre-approval period in France Source: Eur Respir J 2007; 30: Suppl. 51, 621s Year: 2007